S-8921 (Shionogi)
- PMID: 11575711
S-8921 (Shionogi)
Abstract
S-8921 is a sodium/bile acid transport inhibitor under development by Shionogi for the potential treatment of hyperlipidemia. As of June 2000, phase I trials had commenced in Japan and were planned in Europe [370602]. S-8921 acts by altering sodium-dependent transport mechanisms of the brush-borders in the intestinal mucosa, causing bile acids that re-enter the intestine to be excreted rather than reabsorbed [281476].
Similar articles
-
Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption.J Pharmacol Exp Ther. 1998 Jan;284(1):43-50. J Pharmacol Exp Ther. 1998. PMID: 9435159
-
The role of cytoplasmic proteins in hepatic bile acid transport.Annu Rev Physiol. 1989;51:161-76. doi: 10.1146/annurev.ph.51.030189.001113. Annu Rev Physiol. 1989. PMID: 2653179 Review. No abstract available.
-
Cholesterol absorption inhibitors in development as potential therapeutics.Expert Opin Investig Drugs. 2002 Jun;11(6):831-5. doi: 10.1517/13543784.11.6.831. Expert Opin Investig Drugs. 2002. PMID: 12036426 Review.
-
Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.Endocrinol Metab Clin North Am. 2009 Mar;38(1):79-97. doi: 10.1016/j.ecl.2008.11.007. Endocrinol Metab Clin North Am. 2009. PMID: 19217513 Review.
-
Drug evaluation: The MTP inhibitor JTT-130 as a potential treatment for hyperlipidemia.IDrugs. 2006 Jul;9(7):495-9. IDrugs. 2006. PMID: 16821163
Cited by
-
Treating hypercholesterolemia: looking forward.Clin Cardiol. 2003 Jan;26(1 Suppl 1):I21-8. doi: 10.1002/clc.4960261307. Clin Cardiol. 2003. PMID: 12539819 Free PMC article. Review.
-
Role of the intestinal bile acid transporters in bile acid and drug disposition.Handb Exp Pharmacol. 2011;(201):169-203. doi: 10.1007/978-3-642-14541-4_4. Handb Exp Pharmacol. 2011. PMID: 21103970 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials